Congress expands small-business R&D funding, mandates diversity outreach

What it does

This bill reauthorizes and expands the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through 2030, increasing the percentage of federal R&D budgets agencies must allocate to these programs (from current levels to 7% by 2032), and adding new requirements for fellowship programs, diversity outreach, commercialization support, and reporting on research institutions and technology transfer outcomes.

Why we flagged it

The bill's core mechanism is reauthorization and expansion of federal R&D funding set-asides for small businesses, with new diversity and commercialization requirements. It is a straightforward programmatic reauthorization with enhanced accountability measures.

What the text implies

• Section 505 codifies restrictions on SBIR participation by small businesses majority-owned by venture capital, hedge funds, or private equity firms if they are controlled by 'covered foreign entities'—this creates a national-security screening mechanism within the SBIR program that may affect startup funding structures.
• Section 506 (Commercialization Impact Assessment) requires tracking of 9-year revenue and employment outcomes for high-award recipients, creating a longitudinal dataset on SBIR/STTR ROI that could inform future program design or justify expansion/contraction.
• Section 504 (NIH Pilot) allows NIH to use alternative peer-review procedures and deem them compliant with Public Health Service Act requirements—this may reduce procedural rigor or create a precedent for other agencies to streamline review at the cost of consistency.
• Section 402 expands 'direct to Phase II' authority to all SBIR-participating agencies (not just NIH, DoD, Education) with a 10% cap (15% for NIH), potentially accelerating funding but reducing Phase I screening rigor across the federal R&D portfolio.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands federal R&D funding access for small businesses, with explicit mechanisms to increase participation by women, socially disadvantaged, and economically disadvantaged entrepreneurs, and underrepresented geographic regions. It also mandates commercialization support and transparency reporting, which benefits the broader public by accelerating technology transfer and economic opportunity.

Who stands to gain

• Small businesses participating in SBIR/STTR programs
• Women-owned small businesses
• Socially and economically disadvantaged small business owners
• Small businesses in underrepresented geographic regions
• Research institutions (universities, nonprofits, FFRDCs) subcontracted by SBIR/STTR awardees
• Third-party technical and business assistance vendors
• Nonprofit organizations providing outreach and fellowship support

Named in the bill

Small Business Administration (SBA), National Institutes of Health (NIH), Department of Defense (DoD), National Science Foundation (NSF), Department of Energy (DoE), Department of Health and Human Services (HHS), NASA, General Services Administration (GSA), Comptroller General of the United States, Minority institutions (as defined in Higher Education Act), Hispanic-serving institutions, Tribal Colleges and Universities — and 2 more

Where it stands

1 cosponsor: 1 Democrats.

• May 1, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• May 1, 2025 — Referred to Senate Committee on Small Business and Entrepreneurship · Congress.gov: “Read twice and referred to the Committee on Small Business and Entrepreneurship”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,748,000 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

Ed Markey, the sponsor, reported $584,610 in PAC receipts in the 2026 cycle.

• Biotechnology Innovation Organization — $2,360,000 on 1 filing
• Association for Uncrewed Vehicle Systems International — $228,000 on 2 filings
• Boston University — $50,000 on 1 filing
• Activate Global, Inc. — $40,000 on 1 filing
• Venturewell — $40,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.